Procept Biorobotics Corp
PRCT58.930USD
+1.890+3.31%
Handelsschluss 07/17, 16:00（ET）Kurse um 15 Minuten verzögert
3.26BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über Procept Biorobotics Corp Unternehmen
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Unternehmensinformationen
BörsenkürzelPRCT
Name des UnternehmensProcept Biorobotics Corp
IPO-datumSep 15, 2021
Gegründet am2021
CEODr. Reza Zadno, Ph.D.
Anzahl der mitarbeiter756
WertpapierartOrdinary Share
GeschäftsjahresendeSep 15
Addresse150 Baytech Drive
StadtSAN JOSE
BörseNASDAQ Global Market Consolidated
LandUnited States of America
Postleitzahl95134
Telefon16502329832
Websitehttps://www.procept-biorobotics.com/
BörsenkürzelPRCT
IPO-datumSep 15, 2021
Gegründet am2021
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
843.16K
+0.18%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-6.22%
Dr. Reza Zadno, Ph.D.
Dr. Reza Zadno, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.97K
+26.35%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+11.97%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Mr. Larry L. Wood
Mr. Larry L. Wood
Independent Director
Independent Director
5.97K
+34.72%
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
3.90K
+65.22%
Ms. Alaleh Azarkhish Nouri
Ms. Alaleh Azarkhish Nouri
Executive Vice President, Chief Legal Officer, Corporate Secretary
Executive Vice President, Chief Legal Officer, Corporate Secretary
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
843.16K
+0.18%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-6.22%
Dr. Reza Zadno, Ph.D.
Dr. Reza Zadno, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.97K
+26.35%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+11.97%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Hand pieces and other consumables
42.49M
61.43%
System sales and rentals
22.54M
32.59%
Service
4.13M
5.98%
Nach RegionUSD
Name
Umsatz
Anteil
United States
60.29M
87.18%
Outside United States
8.87M
12.82%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Hand pieces and other consumables
42.49M
61.43%
System sales and rentals
22.54M
32.59%
Service
4.13M
5.98%
Aktionärsstatistik
Aktualisiert: Sun, Jun 8
Aktualisiert: Sun, Jun 8
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
14.67%
The Vanguard Group, Inc.
9.25%
BlackRock Institutional Trust Company, N.A.
6.24%
AllianceBernstein L.P.
3.87%
T. Rowe Price Investment Management, Inc.
2.56%
Other
63.41%
Aktionäre
Aktionäre
Anteil
Fidelity Management & Research Company LLC
14.67%
The Vanguard Group, Inc.
9.25%
BlackRock Institutional Trust Company, N.A.
6.24%
AllianceBernstein L.P.
3.87%
T. Rowe Price Investment Management, Inc.
2.56%
Other
63.41%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
45.36%
Investment Advisor/Hedge Fund
34.67%
Hedge Fund
7.57%
Individual Investor
4.25%
Research Firm
3.31%
Bank and Trust
1.10%
Pension Fund
0.73%
Venture Capital
0.66%
Family Office
0.08%
Other
2.26%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
528
53.99M
97.59%
-2.22M
2025Q1
539
53.99M
97.68%
-2.82M
2024Q4
499
53.70M
99.42%
+875.53K
2024Q3
449
49.13M
94.16%
-1.41M
2024Q2
393
47.17M
91.61%
-2.29M
2024Q1
345
48.36M
95.04%
-4.45M
2023Q4
326
47.80M
94.81%
-4.63M
2023Q3
322
46.77M
93.30%
+2.15M
2023Q2
298
38.23M
84.44%
-1.74M
2023Q1
275
35.37M
78.88%
-3.41M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Fidelity Management & Research Company LLC
8.12M
14.67%
+55.63K
+0.69%
Mar 31, 2025
The Vanguard Group, Inc.
5.12M
9.25%
-14.09K
-0.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.45M
6.24%
-11.08K
-0.32%
Mar 31, 2025
AllianceBernstein L.P.
2.14M
3.87%
+391.21K
+22.32%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.42M
2.56%
+429.46K
+43.56%
Mar 31, 2025
State Street Global Advisors (US)
1.19M
2.15%
-1.44K
-0.12%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.18M
2.14%
+19.63K
+1.69%
Mar 31, 2025
Loomis, Sayles & Company, L.P.
1.18M
2.14%
-25.76K
-2.13%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.01M
1.83%
+334.20K
+49.20%
Mar 31, 2025
Wellington Management Company, LLP
962.24K
1.74%
-528.72K
-35.46%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sun, Jul 6
Aktualisiert: Sun, Jul 6
Name
Anteil
Global X HealthTech ETF
3.11%
SPDR S&P Health Care Equipment ETF
1.67%
Global X Robotics & Artificial Intelligence ETF
1.37%
Harbor Health Care ETF
1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.17%
ALPS Disruptive Technologies ETF
0.95%
Langar Global HealthTech ETF
0.86%
Main Thematic Innovation ETF
0.5%
BNY Mellon Innovators ETF
0.43%
Nuveen ESG Small-Cap ETF
0.37%
Mehr Anzeigen
Global X HealthTech ETF
Anteil3.11%
SPDR S&P Health Care Equipment ETF
Anteil1.67%
Global X Robotics & Artificial Intelligence ETF
Anteil1.37%
Harbor Health Care ETF
Anteil1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil1.17%
ALPS Disruptive Technologies ETF
Anteil0.95%
Langar Global HealthTech ETF
Anteil0.86%
Main Thematic Innovation ETF
Anteil0.5%
BNY Mellon Innovators ETF
Anteil0.43%
Nuveen ESG Small-Cap ETF
Anteil0.37%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
